Drug shortages: clinical implications and burdens – a trinational multiple-methods study including key stakeholders
The results show that drug shortages have significantly disrupted clinical practice across all three countries, with pharmacists and physicians reporting major impacts on patient care and increased time spent resolving issues. Economic pressures, political factors and regulatory obstacles were identified as key causes exacerbating the crisis and highlighting the need for coordinated mitigation strategies.
Authors
- Kreshnik Hoti (ORCID: https://orcid.org/0000-0001-7652-6074)
- Olaf Rose (ORCID: https://orcid.org/0000-0003-1681-4909)
- Johanna Pachmayr (ORCID: https://orcid.org/0000-0001-9156-591X)
- Stephanie Clemens (ORCID: https://orcid.org/0000-0002-8788-9329)
- A Härtl
- Blete Isufi (ORCID: https://orcid.org/0000-0002-3536-7238)
- Matthias Wachinger
- Heinz Giesen
Institutions
- Paracelsus Medical University (AT)
- Medizinisches Versorgungszentrum Prof. Mathey, Prof. Schofer (DE)
- Post Apotheke (DE)
- University of Prishtina (XK)
Publication Details
- Journal
- Journal of Pharmaceutical Policy and Practice
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1080/20523211.2025.2555731
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00